Clinical Application and Progress of Fecal Microbiota Transplantation in Liver Diseases: A Review

Authors:

Abstract
The human gut harbors a dense and highly diverse microbiota of approximately 1,000 bacterial species. The interaction between the host and gut bacteria strongly influences human health. Numerous evidence suggest that intestinal flora imbalance is closely associated with the development and treatment of liver diseases, including acute liver injury and chronic liver diseases (cirrhosis, autoimmune liver disease, and fatty liver). Therefore, regulating the gut microbiota is expected to be a new method for the adjuvant treatment of liver diseases. Fecal microbiota transplantation (FMT) is defined as the transplantation of gut microbiota from healthy donors to sick patients via the upper or lower gastrointestinal route to restore the normal intestinal balance. In this study, we briefly review the current research on the gut microbiota and its link to liver diseases and then summarize the evidence to elucidate the clinical application and development of FMT in liver disease treatment.
Funding Information
  • National Natural Science Foundation of China (81904129)
  • College Student Innovation Funds Project for the Hebei University of Chinese Medicine (31800952)
  • College Student Innovation Funds Project for the Hebei University of Chinese Medicine (202014432203)
  • Fundamental Research Funds for the Southeast University (3218006405)
  • Fundamental Research Funds for the Southeast University (2242019s10024)

This publication has 96 references indexed in Scilit: